BG96645A - Етилендиаминови моноамиди - Google Patents

Етилендиаминови моноамиди

Info

Publication number
BG96645A
BG96645A BG096645A BG9664592A BG96645A BG 96645 A BG96645 A BG 96645A BG 096645 A BG096645 A BG 096645A BG 9664592 A BG9664592 A BG 9664592A BG 96645 A BG96645 A BG 96645A
Authority
BG
Bulgaria
Prior art keywords
monamides
ethylene diamine
parkinsonism
marked
denotes
Prior art date
Application number
BG096645A
Other languages
English (en)
Other versions
BG60401B1 (bg
Inventor
Rene Inhof
Emilio Kyburz
Original Assignee
Hoffmann-La Roche Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH4132/84A external-priority patent/CH661043A5/de
Priority claimed from CH2404/85A external-priority patent/CH664755A5/de
Application filed by Hoffmann-La Roche Inc. filed Critical Hoffmann-La Roche Inc.
Publication of BG96645A publication Critical patent/BG96645A/bg
Publication of BG60401B1 publication Critical patent/BG60401B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Изобретението се отнася до етилендиаминови моноамидни производни с формулав която r означава ароматен 5или 6-членен хетероцикличен остатък, и/или техните фармацевтично приложими, присъединителни с киселина соли. Съединенията имат подчертани инхибиращи моноаминоксидазата свойства, ниска токсичност и могат да се използват за лечение на депресивни състояния и паркинсонизъм. 17 претенции
BG96645A 1984-08-29 1992-07-17 Етилендиаминови моноамиди BG60401B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH4132/84A CH661043A5 (en) 1984-08-29 1984-08-29 Ethylenediamine monoamide derivatives
CH2404/85A CH664755A5 (de) 1985-06-05 1985-06-05 Aethylendiaminmonoamid-derivat.

Publications (2)

Publication Number Publication Date
BG96645A true BG96645A (bg) 1993-12-24
BG60401B1 BG60401B1 (bg) 1995-02-28

Family

ID=25690366

Family Applications (1)

Application Number Title Priority Date Filing Date
BG96645A BG60401B1 (bg) 1984-08-29 1992-07-17 Етилендиаминови моноамиди

Country Status (28)

Country Link
US (1) US4764522A (bg)
JP (2) JPH0764817B2 (bg)
KR (1) KR920007269B1 (bg)
AR (1) AR244209A1 (bg)
AT (1) AT391694B (bg)
AU (1) AU582381B2 (bg)
BE (1) BE903110A (bg)
BG (1) BG60401B1 (bg)
CA (1) CA1261335A (bg)
DE (1) DE3530046C2 (bg)
DK (1) DK162888C (bg)
ES (2) ES8705372A1 (bg)
FI (1) FI83511C (bg)
FR (1) FR2569694B1 (bg)
GB (1) GB2163746B (bg)
GR (1) GR852071B (bg)
HU (1) HU197309B (bg)
IE (1) IE58788B1 (bg)
IL (1) IL76176A (bg)
IT (1) IT1190385B (bg)
LU (1) LU86049A1 (bg)
MC (1) MC1696A1 (bg)
NL (1) NL193583C (bg)
NO (1) NO169711C (bg)
NZ (1) NZ213193A (bg)
PH (1) PH22813A (bg)
PT (1) PT81041B (bg)
SE (1) SE464083B (bg)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0352581A3 (de) * 1988-07-28 1990-07-04 F. Hoffmann-La Roche Ag Aethylendiaminmonoamid-Derivate
US5204482A (en) * 1988-07-28 1993-04-20 Hoffman-Laroche Inc. Compounds for treating and preventing cognitive diseases and depression and methods of making same
CA2245055C (en) * 1989-02-28 2003-03-25 F. Hoffmann-La Roche Ag Amidation of pyridines
EP0451790A1 (de) * 1990-04-12 1991-10-16 Hoechst Aktiengesellschaft 3,5-disubstituierte 2-Isoxazoline und Isoxazole, Verfahren zu deren Herstellung, diese enthaltende Mittel und ihre Verwendung
JPH04295470A (ja) * 1991-03-22 1992-10-20 Wakamoto Pharmaceut Co Ltd モノアミンオキシダーゼ−ｂ酵素阻害活性を有する１，２，４−オキサジアゾール誘導体及びその製造法
RU2097378C1 (ru) * 1991-03-26 1997-11-27 Ф.Хоффманн-Ля Рош Аг ПРОИЗВОДНЫЕ N-АЦИЛ- α -АМИНОКИСЛОТЫ ИЛИ ИХ ФИЗИОЛОГИЧЕСКИ ПРИЕМЛЕМЫЕ СОЛИ, ПРОСТЫЕ ИЛИ СЛОЖНЫЕ ЭФИРЫ, АМИДЫ ИЛИ ГИДРАТЫ И КОМПОЗИЦИЯ ИНГИБИРУЮЩАЯ СВЯЗЫВАНИЕ АДГЕЗИВНЫХ ПРОТЕИНОВ С ТРОМБОЦИТАМИ И АГРЕГАЦИЮ ТРОМБОЦИТОВ
US5545658A (en) * 1991-03-26 1996-08-13 Hoffman-La Roche Inc. Amino acid derivatives
FR2803592A1 (fr) * 2000-01-06 2001-07-13 Aventis Cropscience Sa Nouveaux derives de l'acide 3-hydroxypicolinique, leur procede de preparation et compositions fongicides les contenant.
JP2005524612A (ja) * 2001-12-06 2005-08-18 ファイブローゲン、インコーポレーテッド 内因性エリスロポエチン（ｅｐｏ）を増加させる方法
US6667327B2 (en) 2002-02-04 2003-12-23 Hoffmann-La Roche Inc. Pyridine amido derivatives
DE602004017206D1 (de) * 2003-10-23 2008-11-27 Hoffmann La Roche Benzazepin-derivate als mao-b-hemmer
WO2007008963A1 (en) * 2005-07-13 2007-01-18 Jenrin Discovery Mao-b inhibitors useful for treating obesity
WO2008010796A1 (en) * 2006-07-18 2008-01-24 Renaissance Medicine, Llc Process for preparing pyridine-2-carboxamides and intermediates therefor
WO2008010794A1 (en) * 2006-07-18 2008-01-24 Renaissance Medicine, Llc Pharmaceutical preparations of crystalline lazabemide
FR2904317A1 (fr) * 2006-07-27 2008-02-01 Inst Nat Sante Rech Med Analogues d'halogenobenzamides marques a titre de radiopharmaceutiques
EP2085390A1 (en) 2008-01-31 2009-08-05 Institut National De La Sante Et De La Recherche Medicale (Inserm) Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors
WO2011028740A1 (en) * 2009-09-03 2011-03-10 Glaxo Group Limited ENaC BLOCKERS
CA2914662C (en) * 2013-06-13 2022-05-31 Robert Shalwitz Compositions and methods for treating anemia
KR20240038132A (ko) 2015-04-01 2024-03-22 아케비아 테라퓨틱스 인코포레이티드 빈혈 치료용 조성물 및 방법
WO2019028150A1 (en) 2017-08-01 2019-02-07 Akebia Therapeutics, Inc. COMPOSITIONS FOR USE IN METHODS OF TREATING HEMOGLOBINOPATHIES

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB451304A (en) * 1934-07-07 1936-08-04 Karl Merck Process for the manufacture of new derivatives of pyrazinemonocarboxylic acid
NL300271A (bg) * 1962-11-09
NL6707566A (bg) * 1966-08-17 1968-02-19
GB1509527A (en) * 1974-06-05 1978-05-04 Ici Ltd 1-(aryl-or heteroaryl)oxy-3-(substituted-amino)propan-2-ol derivatives processes for their manufacture and pharmaceutical compositions containing them
US4041032A (en) * 1974-01-16 1977-08-09 Yamanouchi Pharmaceutical Co., Ltd. Pyrazine derivatives
GB1509300A (en) * 1975-12-05 1978-05-04 Ici Ltd Ethanolamine derivatives
DE3239573A1 (de) * 1981-10-28 1983-05-19 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Substituierte picolinsaeuren, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende arzneimittel
IE54220B1 (en) * 1981-12-23 1989-07-19 Ici Plc Phenol esters
CH653670A5 (de) * 1983-03-03 1986-01-15 Hoffmann La Roche Benzamid-derivate.

Also Published As

Publication number Publication date
GR852071B (bg) 1985-12-24
FI83511B (fi) 1991-04-15
ES8800158A1 (es) 1987-11-01
SE464083B (sv) 1991-03-04
DK162888B (da) 1991-12-23
PH22813A (en) 1988-12-27
NL193583B (nl) 1999-11-01
NO169711B (no) 1992-04-21
DK391485D0 (da) 1985-08-28
AU582381B2 (en) 1989-03-23
HUT38317A (en) 1986-05-28
NL193583C (nl) 2000-03-02
GB2163746A (en) 1986-03-05
FR2569694A1 (fr) 1986-03-07
HU197309B (en) 1989-03-28
ES546482A0 (es) 1987-05-01
US4764522A (en) 1988-08-16
JPH0764817B2 (ja) 1995-07-12
PT81041A (en) 1985-09-01
IT8521865A0 (it) 1985-08-05
BE903110A (fr) 1986-02-24
SE8504014L (sv) 1986-03-01
JPH0825879B2 (ja) 1996-03-13
IE58788B1 (en) 1993-11-17
FI853140L (fi) 1986-03-01
NL8502374A (nl) 1986-03-17
GB2163746B (en) 1988-06-22
IL76176A0 (en) 1985-12-31
ES552399A0 (es) 1987-11-01
ES8705372A1 (es) 1987-05-01
FI83511C (fi) 1991-07-25
MC1696A1 (fr) 1986-07-18
DE3530046C2 (de) 1997-12-04
NZ213193A (en) 1989-10-27
GB8521358D0 (en) 1985-10-02
DK162888C (da) 1992-05-11
PT81041B (pt) 1988-01-22
AT391694B (de) 1990-11-12
NO169711C (no) 1992-07-29
JPH07300417A (ja) 1995-11-14
BG60401B1 (bg) 1995-02-28
AR244209A1 (es) 1993-10-29
ATA251585A (de) 1990-05-15
IL76176A (en) 1989-02-28
AU4663685A (en) 1986-03-06
KR920007269B1 (ko) 1992-08-29
KR870002078A (ko) 1987-03-30
NO853390L (no) 1986-03-03
JPS6160657A (ja) 1986-03-28
CA1261335A (en) 1989-09-26
IE852118L (en) 1986-02-28
LU86049A1 (de) 1986-09-11
FR2569694B1 (fr) 1991-05-03
DK391485A (da) 1986-03-01
SE8504014D0 (sv) 1985-08-28
IT1190385B (it) 1988-02-16
DE3530046A1 (de) 1986-03-13
FI853140A0 (fi) 1985-08-15

Similar Documents

Publication Publication Date Title
BG96645A (bg) Етилендиаминови моноамиди
ES2056190T3 (es) Derivados de 4(4-fenil-1-piperazinil)fenoles, inhibidores de 5-lipoxigenasa.
BR9206161A (pt) Derivados fluoroalcoxibenzilamino de heterociclos contendo nitrogénio
SE8503680L (sv) Indolderivat
FI913478A0 (fi) Diazinderivat.
YU47116B (sh) Postupak za dobijanje novih n-supstituisanih benzimidazolskih derivata
DK229187D0 (da) 1-substituerede imidazolderivater, 2-thion-tautomere og ikke-toksiske, farmaceutisk acceptable salte deraf
EA200000320A1 (ru) Изохинолины в качестве ингибиторов урокиназы
ATE181731T1 (de) Isothioharnstoff-derivate als no synthase hemmer
SE8107273L (sv) 2-oxoazetidinderivat, sett att framstella democh anvendning derav
ES2096874T3 (es) Inhibidor de la proteasa de hiv util para el tratamiento del sida.
ES539160A0 (es) Un procedimiento para preparar derivados de penem
ES2032437T3 (es) Inmunoestimulantes heptanoil-glu-asp-ala-aminoacidos.
ES8604853A1 (es) Un metodo para la preparacion de un derivado de acetileno.
FI853470A0 (fi) Foerfarande foer framstaellning av saosom antimikrobiella aemnen anvaendbara n-/1-alkyl- eller arylmetyl)-4 (1h)pyridinylidin/alkanaminer.
ATE113843T1 (de) Verwendung eines prolylendopeptidase-inhibitors zur behandlung von aids.
ATE207063T1 (de) Uracilderivate
UA26982A1 (uk) Похідhі малоhової кислоти, які проявляють властивості іhгібітору росту рослиh
NO912420L (no) Antiatherosklerotiske og antitrombotiske 1-benzopyran-4-oner og 2-amino-1,3-benzoksazin-4-oner.
JO1648B1 (en) Nitrogen compounds